Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review

December 2021 | 50 pages | ID: T0F044C2AAAEN
GlobalData

Abstracts

Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Theratechnologies Inc (Theratechnologies) is a biopharmaceutical company that focuses on the discovery and development of drugs for people with orphan medical conditions. The company’s marketed products include Egrifta (tesamorelin for injection) and Egrifta SV is indicated to reduce excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, CD-4 directed post-attachment HIV-1 inhibitor indicated for HIV type 1 infection in the US. Its pipeline products include Trogarzo IV slow push for HIV and Egrifta F8 for NASH HIV.The company is also developing TH 1902 for triple negative breast cancer and TH1904 for ovarian cancer. It develops products based on peptide stabilization technology to increase target protein resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.

Theratechnologies Inc Key Recent Developments

Nov 23,2021: Theratechnologies announces renewal of shelf prospectus and registration statement; at-the-market facility to be extended
Oct 06,2021: Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference
Sep 29,2021: Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021
Sep 13,2021: Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
Jul 15,2021: Theratechnologies reports financial results for the second quarter of fiscal 2021 and Provides Update on its planned phase 3 clinical trial in NASH

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Theratechnologies Inc - Key Facts
Theratechnologies Inc - Key Employees
Theratechnologies Inc - Key Employee Biographies
Theratechnologies Inc - Major Products and Services
Theratechnologies Inc - History
Theratechnologies Inc - Company Statement
Theratechnologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Theratechnologies Inc - Business Description
Product Category: Egrifta
Performance
Product Category: Trogarzo
Performance
Geographical Segment: Canada
Performance
Geographical Segment: The US
Performance
Theratechnologies Inc - Corporate Strategy
Theratechnologies Inc - SWOT Analysis
SWOT Analysis - Overview
Theratechnologies Inc - Strengths
Theratechnologies Inc - Weaknesses
Theratechnologies Inc - Opportunities
Theratechnologies Inc - Threats
Theratechnologies Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theratechnologies Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 23, 2021: Theratechnologies announces renewal of shelf prospectus and registration statement; at-the-market facility to be extended
Oct 06, 2021: Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference
Sep 29, 2021: Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021
Sep 13, 2021: Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
Jul 15, 2021: Theratechnologies reports financial results for the second quarter of fiscal 2021 and Provides Update on its planned phase 3 clinical trial in NASH
Jun 30, 2021: Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021
Jun 23, 2021: Theratechnologies Appoints Mr. Frank Holler as New Board Member
May 31, 2021: Theratechnologies Hires Vice President, Human Resources
Apr 14, 2021: Theratechnologies Reports First Quarter 2021 Financial Results And Recent Business Highlights
Apr 12, 2021: Theratechnologies To Present At The Bloom Burton & Co. Healthcare Investor Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Theratechnologies Inc, Key Facts
Theratechnologies Inc, Key Employees
Theratechnologies Inc, Key Employee Biographies
Theratechnologies Inc, Major Products and Services
Theratechnologies Inc, History
Theratechnologies Inc, Other Locations
Theratechnologies Inc, Subsidiaries
Theratechnologies Inc, Key Competitors
Theratechnologies Inc, Ratios based on current share price
Theratechnologies Inc, Annual Ratios
Theratechnologies Inc, Annual Ratios (Cont...1)
Theratechnologies Inc, Annual Ratios (Cont...2)
Theratechnologies Inc, Interim Ratios
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theratechnologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Theratechnologies Inc, Performance Chart (2016 - 2020)
Theratechnologies Inc, Ratio Charts
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021